OLIVERO, Martina
OLIVERO, Martina
ONCOLOGIA
17beta-oestradiol-induced gene expression in cattle prostate: biomarkers to detect illegal use of growth promoters
2009-01-01 De Maria R; Divari S; Goria M; Bollo E; Cannizzo FT; Olivero M; Barbarino G; Biolatti B.
A cancer-predisposing "hot spot" mutation of the fumarase gene creates a dominant negative protein
2008-01-01 LORENZATO A; OLIVERO M; PERRO M; BRIERE JJ; RUSTIN P; M. DI RENZO
A mouse model of pulmonary metastasis from spontaneous osteosarcoma monitored in vivo by Luciferase imaging
2008-01-01 MIRETTI S; ROATO I; TAULLI R; PONZETTO C; CILLI M; OLIVERO M; DI RENZO M; GODIO L; ALBINI A; BURACCO P; FERRACINI R
Abstract 3102: Identification of actionable cancer genes and treatment options for metastatic ovarian carcinomas using patient-derived xenografts and PDX-derived tumor cells
2018-01-01 Olivero, Martina; Erriquez, Jessica; Arigoni, Maddalena; Capellero, Sonia; D'Ambrosio, Concetta; Mittica, Gloria; Borella, Fulvio; Katsaros, Dionyssios; Privitera, Silvana; Berrino, Enrico; Venesio, Tiziana; Valabrega, Giorgio; Calogero, Raffaele; Renzo, Maria Flavia Di
AKT activation drives the nuclear localization of CSE1L and a pro-oncogenic transcriptional activation in ovarian cancer cells.
2013-01-01 Lorenzato A;Biolatti M;Delogu G;Capobianco G;Farace C;Dessole S;Cossu A;Tanda F;Madeddu R;Olivero M;Di Renzo MF
Amplification of repeat-containing transcribed sequences (ARTS): a transcriptome fingerprinting strategy to detect functionally relevant microsatellite mutations in cancer.
2003-01-01 OLIVERO M ;RUGGIERO T ;COLTELLA N ;MAFFE' A ;CALOGERO R ;MEDICO E ;DI RENZO MF
Attivazione e caratterizzazione molecolare dell’oncogene AKT nei tumori mammari felini.
2009-01-01 Maniscalco L.; De Maria R.; Iussich S.; Martín De Las Mulas J.; Olivero M.; Millán Y; Biolatti B.
Cancer Cells Haploinsufficient for ATM Are Sensitized to PARP Inhibitors by MET Inhibition
2022-01-01 D'Ambrosio, Concetta; Erriquez, Jessica; Capellero, Sonia; Cignetto, Simona; Alvaro, Maria; Ciamporcero, Eric; Di Renzo, Maria Flavia; Perera, Timothy; Valabrega, Giorgio; Olivero, Martina
Caveolin-1 reduces osteosarcoma metastases by inhibiting c-Src activity and met signaling
2007-01-01 CANTIANI L; MANARA MC; ZUCCHINI C; DE SANCTIS P; ZUNTINI M; VALVASSORI L; SERRA M; OLIVERO M; DI RENZO M; COLOMBO MP; PICCI P; SCOTLANDI K
Cells lacking the fumarase tumor suppressor are protected from apoptosis through a HIF-independent, AMPK dependent mechanism.
2012-01-01 Bardella C;Olivero M;Lorenzato A;Geuna M;Adam J;O'Flaherty L;Rustin P;Tomlinson I;Pollard PJ;Di Renzo MF
Circulating Extracellular Vesicles Contain Liver-Derived RNA Species as Indicators of Severe Cholestasis-Induced Early Liver Fibrosis in Mice
2022-01-01 Fagoonee, Sharmila; Arigoni, Maddalena; Manco, Marta; Olivero, Martina; Bizzaro, Francesca; Magagnotti, Cinzia; Andolfo, Annapaola; Miniscalco, Barbara; Forni, Marco; Todeschi, Stefano; Tolosano, Emanuela; Bocchietto, Elena; Calogero, Raffaele; Altruda, Fiorella
Cisplatin unveils cancer cell addiction to the non-oncogene CDT2
2009-01-01 Olivero M; Dettori D; Lorenzato A; Martino C; Musiani D; Orlando G; Di Renzo MF
Control of invasive growth by the HGF receptor family.
1997-01-01 MAGGIORA P; GAMBAROTTA G; OLIVERO M; S. GIORDANO; DI RENZO MF; COMOGLIO PM
CSE1L as a Potential Target to Sensitize Ovarian Cancer Cells to Cisplatin
2010-01-01 Lorenzato A; Olivero M; Calogero R., Martino C, Musiani D, Dani N, Di Renzo MF
Deletion in a (T)8 microsatellite abrogates expression regulation by 3'-UTR.
2003-01-01 RUGGIERO T ;OLIVERO M ;FOLLENZI A ;NALDINI L ;CALOGERO R ;DI RENZO MF
Detection of MET oncogene/hepatocyte growth factor receptor in lymph node metastases from head and neck squamous cell carcinomas.
1997-01-01 GALEAZZI E ;OLIVERO M ;GERVASIO FC ;DE STEFANI A ;VALENTE G ;COMOGLIO PM ;DI RENZO MF ;CORTESINA G
Different mirna profiles in plasma derived small and large extracellular vesicles from patients with neurodegenerative diseases
2021-01-01 Sproviero D.; Gagliardi S.; Zucca S.; Arigoni M.; Giannini M.; Garofalo M.; Olivero M.; Dell'orco M.; Pansarasa O.; Bernuzzi S.; Avenali M.; Ramusino M.C.; Diamanti L.; Minafra B.; Perini G.; Zangaglia R.; Costa A.; Ceroni M.; Perrone-bizzozero N.I.; Calogero R.A.; Cereda C.
DNA damage stress phenotype makes cancer cells addicted to a redundant CUL4 dependent pathway
2011-01-01 Olivero M; Dettori D; Pavan S; Di Renzo MF
Early stability and late random tumor progression of a HER2-positive primary breast cancer patient-derived xenograft
2021-01-01 Landuzzi L.; Palladini A.; Ceccarelli C.; Asioli S.; Nicoletti G.; Giusti V.; Ruzzi F.; Ianzano M.L.; Scalambra L.; Laranga R.; Balboni T.; Arigoni M.; Olivero M.; Calogero R.A.; De Giovanni C.; Dall'Ora M.; Di Oto E.; Santini D.; Foschini M.P.; Cucchi M.C.; Zanotti S.; Taffurelli M.; Nanni P.; Lollini P.-L.
Expression of Hepatocyte Growth Factor (HGF) and its Receptor (MET) in Medullary Carcinoma of the Thyroid.
2000-01-01 PAPOTTI M; OLIVERO M; VOLANTE M; NEGRO F; PRAT M; COMOGLIO PM; M. DI RENZO
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
17beta-oestradiol-induced gene expression in cattle prostate: biomarkers to detect illegal use of growth promoters | 2009 | De Maria R; Divari S; Goria M; Bollo E; Cannizzo FT; Olivero M; Barbarino G; Biolatti B. | |
A cancer-predisposing "hot spot" mutation of the fumarase gene creates a dominant negative protein | 2008 | LORENZATO A; OLIVERO M; PERRO M; BRIERE JJ; RUSTIN P; M. DI RENZO | |
A mouse model of pulmonary metastasis from spontaneous osteosarcoma monitored in vivo by Luciferase imaging | 2008 | MIRETTI S; ROATO I; TAULLI R; PONZETTO C; CILLI M; OLIVERO M; DI RENZO M; GODIO L; ALBINI A; BURACCO P; FERRACINI R | |
Abstract 3102: Identification of actionable cancer genes and treatment options for metastatic ovarian carcinomas using patient-derived xenografts and PDX-derived tumor cells | 2018 | Olivero, Martina; Erriquez, Jessica; Arigoni, Maddalena; Capellero, Sonia; D'Ambrosio, Concetta; Mittica, Gloria; Borella, Fulvio; Katsaros, Dionyssios; Privitera, Silvana; Berrino, Enrico; Venesio, Tiziana; Valabrega, Giorgio; Calogero, Raffaele; Renzo, Maria Flavia Di | |
AKT activation drives the nuclear localization of CSE1L and a pro-oncogenic transcriptional activation in ovarian cancer cells. | 2013 | Lorenzato A;Biolatti M;Delogu G;Capobianco G;Farace C;Dessole S;Cossu A;Tanda F;Madeddu R;Olivero M;Di Renzo MF | |
Amplification of repeat-containing transcribed sequences (ARTS): a transcriptome fingerprinting strategy to detect functionally relevant microsatellite mutations in cancer. | 2003 | OLIVERO M ;RUGGIERO T ;COLTELLA N ;MAFFE' A ;CALOGERO R ;MEDICO E ;DI RENZO MF | |
Attivazione e caratterizzazione molecolare dell’oncogene AKT nei tumori mammari felini. | 2009 | Maniscalco L.; De Maria R.; Iussich S.; Martín De Las Mulas J.; Olivero M.; Millán Y; Biolatti B. | |
Cancer Cells Haploinsufficient for ATM Are Sensitized to PARP Inhibitors by MET Inhibition | 2022 | D'Ambrosio, Concetta; Erriquez, Jessica; Capellero, Sonia; Cignetto, Simona; Alvaro, Maria; Ciamporcero, Eric; Di Renzo, Maria Flavia; Perera, Timothy; Valabrega, Giorgio; Olivero, Martina | |
Caveolin-1 reduces osteosarcoma metastases by inhibiting c-Src activity and met signaling | 2007 | CANTIANI L; MANARA MC; ZUCCHINI C; DE SANCTIS P; ZUNTINI M; VALVASSORI L; SERRA M; OLIVERO M; DI RENZO M; COLOMBO MP; PICCI P; SCOTLANDI K | |
Cells lacking the fumarase tumor suppressor are protected from apoptosis through a HIF-independent, AMPK dependent mechanism. | 2012 | Bardella C;Olivero M;Lorenzato A;Geuna M;Adam J;O'Flaherty L;Rustin P;Tomlinson I;Pollard PJ;Di Renzo MF | |
Circulating Extracellular Vesicles Contain Liver-Derived RNA Species as Indicators of Severe Cholestasis-Induced Early Liver Fibrosis in Mice | 2022 | Fagoonee, Sharmila; Arigoni, Maddalena; Manco, Marta; Olivero, Martina; Bizzaro, Francesca; Magagnotti, Cinzia; Andolfo, Annapaola; Miniscalco, Barbara; Forni, Marco; Todeschi, Stefano; Tolosano, Emanuela; Bocchietto, Elena; Calogero, Raffaele; Altruda, Fiorella | |
Cisplatin unveils cancer cell addiction to the non-oncogene CDT2 | 2009 | Olivero M; Dettori D; Lorenzato A; Martino C; Musiani D; Orlando G; Di Renzo MF | |
Control of invasive growth by the HGF receptor family. | 1997 | MAGGIORA P; GAMBAROTTA G; OLIVERO M; S. GIORDANO; DI RENZO MF; COMOGLIO PM | |
CSE1L as a Potential Target to Sensitize Ovarian Cancer Cells to Cisplatin | 2010 | Lorenzato A; Olivero M; Calogero R., Martino C, Musiani D, Dani N, Di Renzo MF | |
Deletion in a (T)8 microsatellite abrogates expression regulation by 3'-UTR. | 2003 | RUGGIERO T ;OLIVERO M ;FOLLENZI A ;NALDINI L ;CALOGERO R ;DI RENZO MF | |
Detection of MET oncogene/hepatocyte growth factor receptor in lymph node metastases from head and neck squamous cell carcinomas. | 1997 | GALEAZZI E ;OLIVERO M ;GERVASIO FC ;DE STEFANI A ;VALENTE G ;COMOGLIO PM ;DI RENZO MF ;CORTESINA G | |
Different mirna profiles in plasma derived small and large extracellular vesicles from patients with neurodegenerative diseases | 2021 | Sproviero D.; Gagliardi S.; Zucca S.; Arigoni M.; Giannini M.; Garofalo M.; Olivero M.; Dell'orco M.; Pansarasa O.; Bernuzzi S.; Avenali M.; Ramusino M.C.; Diamanti L.; Minafra B.; Perini G.; Zangaglia R.; Costa A.; Ceroni M.; Perrone-bizzozero N.I.; Calogero R.A.; Cereda C. | |
DNA damage stress phenotype makes cancer cells addicted to a redundant CUL4 dependent pathway | 2011 | Olivero M; Dettori D; Pavan S; Di Renzo MF | |
Early stability and late random tumor progression of a HER2-positive primary breast cancer patient-derived xenograft | 2021 | Landuzzi L.; Palladini A.; Ceccarelli C.; Asioli S.; Nicoletti G.; Giusti V.; Ruzzi F.; Ianzano M.L.; Scalambra L.; Laranga R.; Balboni T.; Arigoni M.; Olivero M.; Calogero R.A.; De Giovanni C.; Dall'Ora M.; Di Oto E.; Santini D.; Foschini M.P.; Cucchi M.C.; Zanotti S.; Taffurelli M.; Nanni P.; Lollini P.-L. | |
Expression of Hepatocyte Growth Factor (HGF) and its Receptor (MET) in Medullary Carcinoma of the Thyroid. | 2000 | PAPOTTI M; OLIVERO M; VOLANTE M; NEGRO F; PRAT M; COMOGLIO PM; M. DI RENZO |